Protezione renale (CKD) Solo semaglutide ha un trial dedicato Semaglutide FLOW (NEJM 2024) Tirzepatide Analisi secondarie Verdetto: sul rene la semaglutide ha unevidenza solida (FLOW, trial primario interrotto per efficacia), mentre per la tirzepatide ci sono solo segnali positivi da analisi secondarie
If your side effects are moderate to severe, inject in the evening
This private meeting is a time to discuss your health history, get answers to all your questions, and ensure your goals are realistic
Wanting to feel attractive is not a moral failure
A 2023 survey shows that 4% of Americans already follow the keto diet
Additional trials are also underway in participants with type 1 diabetes targeting diverse pathways including oxidative stress, using nicotinamide adenine dinucleotide phosphate oxidase (Nox)-1/4 inhibitors, and the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, using bardoxolone (NCT03366337, NCT03550443) [84, 85]